An observational study investigating the CRY1Δ11 variant associated with delayed sleep–wake patterns and circadian metabolic output.

Autor: Smieszek, Sandra P.¹ (AUTHOR) Sandra.Smieszek@vandapharma.com, Brzezynski, Jennifer L.¹ (AUTHOR), Kaden, Alyssa R.¹ (AUTHOR), Shinn, Jordan A.¹ (AUTHOR), Wang, Jingyuan¹ (AUTHOR), Xiao, Changfu¹ (AUTHOR), Polymeropoulos, Christos¹ (AUTHOR), Özçelik, Tayfun² (AUTHOR), Polymeropoulos, Mihael H.¹ (AUTHOR)

Publikováno v: Scientific Reports. 10/11/2021, Vol. 11 Issue 1, p1-5. 5p.

Genomic and phenotypic characterization of Investigator Global Assessment (IGA) scale-based endotypes in atopic dermatitis

Autor: Smieszek, Sandra P., Przychodzen, Bartlomiej, Welsh, Sarah E., Brzezynski, Jennifer L., Kaden, Alyssa R., Mohrman, Michael, Wang, Jingyuan, Xiao, Changfu, Ständer, Sonja, Birznieks, Gunther, Polymeropoulos, Christos, Polymeropoulos, Mihael H.

Publikováno v: In Journal of the American Academy of Dermatology December 2021 85(6):1638-1640

27595 Neurokinin-1 receptor antagonist tradipitant improves itch associated with mild atopic dermatitis: Results from EPIONE, a randomized clinical trial

Autor: Brzezynski, Jennifer L., Kaden, Alyssa R., Mohrman, Michael A., Wang, Jingyuan, Smieszek, Sandra P., Przychodzen, Bartlomiej, Xiao, Changfu, Polymeropoulos, Christos, Birznieks, Gunther, Polymeropoulos, Mihael H.

Publikováno v: In Journal of the American Academy of Dermatology September 2021 85(3) Supplement:AB154-AB154

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Corrigendum: Case report: A patient with Delayed Sleep-Wake Phase Disorder and Optic Nerve Hypoplasia treated with tasimelteon: a case study.

Autor: Smieszek SP; Vanda Pharmaceuticals Inc., Washington, DC, United States., Kaden AR; Vanda Pharmaceuticals Inc., Washington, DC, United States., Johnson CE; Vanda Pharmaceuticals Inc., Washington, DC, United States., Brzezynski JL; Vanda Pharmaceuticals Inc., Washington, DC, United States., Xiao C; Vanda Pharmaceuticals Inc., Washington, DC, United States., Polymeropoulos CM; Vanda Pharmaceuticals Inc., Washington, DC, United States., Birznieks G; Vanda Pharmaceuticals Inc., Washington, DC, United States., Emsellem HA; The Center for Sleep & Wake Disorders, Chevy Chase, MD, United States.; Department of Neurology, George Washington University, Washington, DC, United States., Polymeropoulos MH; Vanda Pharmaceuticals Inc., Washington, DC, United States.

Publikováno v: Frontiers in neuroscience [Front Neurosci] 2024 Jan 08; Vol. 17, pp. 1344915. Date of Electronic Publication: 2024 Jan 08 (Print Publication: 2023).